Rula Zain
9PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 20, 2024
In BTK, phosphorylated Y223 in the SH3 domain mirrors catalytic activity, but does not influence biological function.H Yesid Estupiñán, Thibault Bouderlique, Chenfei He
|Oct 26, 2022
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance.Aishath Naeem, Filippo Utro, Qing Wang
|Nov 13, 2021
Growth Media Conditions Influence the Secretion Route and Release Levels of Engineered Extracellular Vesicles.Jeremy P Bost, Osama Saher, Daniel Hagey
|Sep 26, 2021
Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients.Lisa Blixt, Gordana Bogdanovic, Marcus Buggert
|Feb 02, 2021
BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib.H Yesid Estupiñán, Qing Wang, Anna Berglöf
|May 18, 2019
Targeted Oligonucleotides for Treating Neurodegenerative Tandem Repeat Diseases.Rula Zain, C I Edvard Smith
Pageof 2
Frequent Collaborators
8 joint publications
C I Edvard Smith
2 joint publications
H Yesid Estupiñán
2 joint publications
Anders Österborg
2 joint publications
Marzia Palma
1 joint publications
Y Vladimir Pabon-Martinez
1 joint publications
Alessandra Villa
1 joint publications
Per T Jørgensen
1 joint publications
Lennart Nilsson
1 joint publications
Gerard C P Schaafsma
1 joint publications
Dara K Mohammad
